Sarepta Elevidys FDA Investigation - Search News

Order byBest matchMost fresh

News

Sarepta can begin shipping Elevidys therapy

Sarepta soars after FDA says some patients can get Elevidys

Sarepta Therapeutics Inc. shares rose sharply early Tuesday after US regulators reversed course and recommended that patients who can walk be allowed to take its gene therapy Elevidys again.

Continue reading

· 4d · on MSN

FDA probes death of patient on Sarepta's Elevidys, partner Roche says death unrelated to therapy

Fierce Pharma · 1d

FDA launches probe into new Elevidys death as Sarepta, Roche stress gene therapy not at fault

Prasad Out at CBER Following Sarepta Rollercoaster and Conservative Criticism

The FDA’s dramatic summer continues to unfold as news broke late Tuesday evening that Vinay Prasad will depart the agency, ...

15h

Sarepta: SRPT Stock To $40?

This regulatory relief, combined with several other compelling catalysts, creates a pathway for the stock to potentially ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results